Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Codex DNA, Inc. (DNAY : NSDQ)
 
 • Company Description   
Codex DNA Inc. is a creator of the BioXp(TM) system, a fully automated benchtop instrument which enables numerous synthetic biology workflows. Codex DNA Inc. is based in SAN DIEGO.

Number of Employees: 42

 
 • Price / Volume Information   
Yesterday's Closing Price: $4.44 Daily Weekly Monthly
20 Day Moving Average: 139,529 shares
Shares Outstanding: 29.40 (millions)
Market Capitalization: $130.53 (millions)
Beta:
52 Week High: $25.70
52 Week Low: $3.43
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 8.03% 17.89%
12 Week -47.70% -44.94%
Year To Date -58.89% -52.08%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
9535 WAPLES STREET SUITE 100
-
SAN DIEGO,CA 92121
USA
ph: 858-228-4115
fax: -
ir@codexdna.com https://codexdna.com
 
 • General Corporate Information   
Officers
Todd R. Nelson - President; Chief Executive Officer and Director
Frank R. Witney - Chair of the Board of Director
Jennifer I. McNealey - Chief Financial Officer
Brent M. Hunter - Senior Director; Corporate Controller
Andrea L. Jackson - Director

Peer Information
Codex DNA, Inc. (ABMD)
Codex DNA, Inc. (DMDS)
Codex DNA, Inc. (CPWY.)
Codex DNA, Inc. (EQUR)
Codex DNA, Inc. (ECIA)
Codex DNA, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 192003101
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/09/22
Share - Related Items
Shares Outstanding: 29.40
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $130.53 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.50 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.03 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/09/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.67
Price/Cash Flow: -
Price / Sales: 9.09
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -4.65%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 83.11%
ROE
03/31/22 - -46.56
12/31/21 - -50.93
09/30/21 - -
ROA
03/31/22 - -36.63
12/31/21 - -41.32
09/30/21 - -
Current Ratio
03/31/22 - 5.48
12/31/21 - 9.57
09/30/21 - 14.93
Quick Ratio
03/31/22 - 5.33
12/31/21 - 9.33
09/30/21 - 14.72
Operating Margin
03/31/22 - -311.52
12/31/21 - -352.79
09/30/21 - -
Net Margin
03/31/22 - -311.52
12/31/21 - -352.79
09/30/21 - -
Pre-Tax Margin
03/31/22 - -311.41
12/31/21 - -352.66
09/30/21 - -
Book Value
03/31/22 - 2.66
12/31/21 - 3.10
09/30/21 - 3.51
Inventory Turnover
03/31/22 - 4.50
12/31/21 - 3.97
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.16
12/31/21 - 0.16
09/30/21 - 0.13
Debt-to-Capital
03/31/22 - 13.71
12/31/21 - 13.43
09/30/21 - 11.74
 

Powered by Zacks Investment Research ©